J&J To Pay States $120M For False Hip Implant Promos

Law360 (January 22, 2019, 7:35 PM EST) -- A Johnson & Johnson unit will pay $120 million to end a wide-ranging investigation into whether it misled customers about the longevity and efficacy of its hip replacement devices, attorneys general in New York and Texas announced Tuesday.

Without admitting liability or misconduct, DePuy Orthopedics Inc. entered into a consent judgment to adjust how it markets and promotes its hip implant products. The investigations were aimed at DePuy’s ASR XL implant, which was recalled in 2010, and the Pinnacle Ultamet, which was discontinued in 2013.

These are the same products that multiple juries had found the company misled customers about in several...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS